athenahealth, Inc. (ATHN) CEO Sells $496,680.00 in Stock
athenahealth, Inc. (NASDAQ:ATHN) CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $124.17, for a total transaction of $496,680.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $39,710,435.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Jonathan Bush also recently made the following trade(s):
- On Friday, September 1st, Jonathan Bush sold 4,000 shares of athenahealth stock. The stock was sold at an average price of $139.77, for a total transaction of $559,080.00.
- On Tuesday, August 1st, Jonathan Bush sold 4,000 shares of athenahealth stock. The stock was sold at an average price of $143.31, for a total transaction of $573,240.00.
athenahealth, Inc. (NASDAQ ATHN) opened at 122.11 on Friday. The stock has a market cap of $4.88 billion, a PE ratio of 154.96 and a beta of 1.76. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66. The company’s 50 day moving average is $131.53 and its 200 day moving average is $129.63.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The company had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same quarter last year, the business posted $0.34 EPS. The firm’s revenue for the quarter was up 15.0% on a year-over-year basis. On average, analysts anticipate that athenahealth, Inc. will post $1.91 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “athenahealth, Inc. (ATHN) CEO Sells $496,680.00 in Stock” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/06/athenahealth-inc-athn-ceo-sells-496680-00-in-stock.html.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC lifted its holdings in athenahealth by 0.8% during the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock valued at $839,803,000 after buying an additional 47,341 shares in the last quarter. Janus Henderson Group PLC bought a new stake in athenahealth during the 2nd quarter valued at about $713,856,000. Morgan Stanley lifted its holdings in athenahealth by 9.7% during the 1st quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares in the last quarter. Vanguard Group Inc. lifted its holdings in athenahealth by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after buying an additional 53,361 shares in the last quarter. Finally, Capital Research Global Investors lifted its holdings in athenahealth by 15.5% during the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock valued at $286,963,000 after buying an additional 273,660 shares in the last quarter.
ATHN has been the subject of several research reports. Citigroup Inc. reiterated a “buy” rating and issued a $169.00 target price (up from $163.00) on shares of athenahealth in a research report on Monday, July 10th. BidaskClub upgraded shares of athenahealth from a “hold” rating to a “buy” rating in a research report on Saturday, June 24th. William Blair reiterated a “market perform” rating on shares of athenahealth in a research report on Friday, July 21st. J P Morgan Chase & Co set a $136.00 target price on shares of athenahealth and gave the stock a “hold” rating in a research report on Wednesday, July 19th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $135.00 target price on shares of athenahealth in a research report on Monday, June 26th. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $149.91.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.